Feasibility of hepatitis B elimination in high-income countries with ongoing immigration

Background & Aims: Addressing HBV is vital to meeting the World Health Organization (WHO)'s viral hepatitis elimination goals, as 47% of viral hepatitis complications can be attributed to HBV. The objective of this study is to develop an agent-based model determining which integrated strategies involving vacci-nation, screening, and treatment would achieve the WHO's goals.Methods: We developed an agent-based model to characterize the HBV epidemic in a high-income country with ongoing immi-gration. The spread of HBV was simulated through sexual networks and perinatal transmission. Model parameters were estimated from the literature and calibrated against historical HBV data. Sensitivity analyses were performed to assess the uncertainty.Results: We predict that under the current strategies, the inci-dence of acute hepatitis B, and HBV-attributable decompensated cirrhosis and hepatocellular carcinoma would decrease by 64.5%, 9.4%, and 10.5% between 2015-2030, respectively. However, the incidence of chronic hepatitis B and liver-related deaths would increase by 26.6% and 1.0% between 2015-2030, respectively. Results were sensitive to the number of immigrants and HBV prevalence in immigrants.Conclusions: The results suggest that the current vaccination, screening, and treatment strategies will be inadequate to achieve WHO elimination goals. Even with extensive integrated scale-up in vaccination, screening, and treatment, the morbidity and mortality targets may not be reachable, highlighting the need for a re-evaluation of the global strategy for HBV, the importance of developing curative therapy for HBV, and of establishing tailored strategies to prevent long-term sequelae and improve health in immigrants.Lay summary: We have developed a model that reflects the dynamics of hepatitis B virus (HBV) transmission in a high -income country with ongoing immigration, which enabled us to forecast the epidemiology of HBV for policy-level decision making. Our analysis suggests that current vaccination, screening, and treatment strategies are inadequate to achieve the WHO goals of eliminating chronic hepatitis B. Even with extensive integrated scale-up in vaccination, screening, and treatment, the morbidity and mortality targets may not be reachable.(c) 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Automated summary

The study suggests that the current strategies for vaccination, screening, and treatment are inadequate to achieve WHO's goal of eliminating chronic hepatitis B. Even with extensive integrated scale-up, the morbidity and mortality targets may not be reachable.